Latest Articles

Publication Date
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India

Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade

AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade

Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE

Published: Feb. 10, 2026, 10:07 a.m.
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug - CNBC TV18

AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug CNBC TV18

Published: Feb. 10, 2026, 6:11 a.m.
Endometriosis Treatment Market Growth, Company Revenue Share, Key Drivers & Trend Analysis By FMI - industrytoday.co.uk

Endometriosis Treatment Market Growth, Company Revenue Share, Key Drivers & Trend Analysis By FMI industrytoday.co.uk

Published: Feb. 9, 2026, 10:44 a.m.
Ionic liquid-coated gold core polymeric nanoparticles for selective neutrophil hitchhiking towards endometriosis treatment - Nature

Ionic liquid-coated gold core polymeric nanoparticles for selective neutrophil hitchhiking towards endometriosis treatment Nature

Published: Feb. 5, 2026, 6:20 p.m.
Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies - Il Sole 24 ORE

Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies Il Sole 24 ORE

Published: Feb. 5, 2026, 10:31 a.m.
Joondalup Health Campus joins global cancer treatment trial - PerthNow

Joondalup Health Campus joins global cancer treatment trial PerthNow

Published: Feb. 4, 2026, 6 p.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - BioSpace

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer BioSpace

Published: Feb. 4, 2026, 4:47 a.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Newswire Canada

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Newswire …

Published: Feb. 3, 2026, 1 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!